• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Pharm Exec 50: The Winners’ Circle

Article

Pharmaceutical Executive

Pharmaceutical ExecutivePharmaceutical Executive-05-01-2008
Volume 0
Issue 0

Your guide to the world's top 50 pharma companies. The giants may be struggling, but even in a tough year, the industry's most successful companies know how to hit the bullseye.

External Link - article-531367.pdf

Articles in this issue
Pharm Exec 50: The Winners’ Circle
i2-523694-1408670090148.gif
How Not to Handle Rebates
i1-517394-1408675958982.jpg
Want to Be in a Health Plan? Think Like One
i8_t-517402-1408675941187.jpg
Special Report: Platform Drugs—Marketing Your Opportunities
i1-517396-1408675955735.jpg
Bringing in the Green
i1-517397-1408675953916.jpg
Boundaries of Expanded Access
i3_t-517399-1408675949623.jpg
Q&A with Barbara Yanni
i1-517390-1408675966395.jpg
Ready, Aim, Sell
i1-517395-1408675957155.jpg
Are You Exposed? Lock Data Down Now
i1-517391-1408675964917.jpg
Staying in the Game
i1-517389-1408675968608.jpg
For the People, By the People
i4-517400-1408675947316.jpg
Under Pressure
i1-517387-1408675972097.jpg
Korea's Dream Market
i1-517388-1408675970785.jpg
Beyond the Norm
i1-517401-1408675944965.jpg
Special Report: Platform Drugs—Opportunities in the Market...
Related Videos
Related Content
Sandra Von Meier

Advancing Healthcare Solutions: Harnessing Collaborative Business Models for Oncology

April 18th 2024
Article

Unique approaches are needed to bring solutions to fighting cancer and bacterial-resistant infections.

Peter Stark

Redefining Commercial with Modern Data for Today’s Complex Therapies: Q&A with Peter Stark, Executive VP and General Manager of Veeva Compass

March 4th 2024
Article

Stark discusses how the ways that data is reshaping commercial strategies.

Dan Rizzo

Two-Way Communication Connects HCPs to Reps in the Moment of Need: Q&A with Dan Rizzo, Veeva Business Consulting

January 11th 2024
Article

HCPs are utilizing new ways of communicating with reps, according to new data.

Dr. Herb Lin, senior research scholar for cyber policy and security at the Center for International Security and Cooperation and Hank J. Holland Fellow in Cyber Policy and Security at the Hoover Institution at Stanford University.

With Most Fortune 500 Companies Unprepared for New SEC Cyber Regulations, What Should Their Board of Directors Do? A Q&A with Dr. Herb Lin, Senior Research Scholar for Cybersecurity at Stanford University

January 8th 2024
Article

As the use of emerging technologies such as generative artificial intelligence continues to grow to support the innovation goals of Fortune 500 companies, so too does the risk of cybersecurity breaches.

Image credit: Naphat | stock.adobe.com

'Faster, Please': Key Challenges in Chemicals and Materials R&D

January 2nd 2024
Article

Companies must address myriad challenges to improve upon issues such as data quality and transparency, process efficiency, and artificial intelligence/machine learning preparedness.

Sonja Rivera

Merck Medical Affairs: An Enterprise-Wide Approach to Customer Intelligence

December 15th 2023
Article

The importance of enabling customer intelligence at scale.